JP5753344B2 - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- JP5753344B2 JP5753344B2 JP2009224001A JP2009224001A JP5753344B2 JP 5753344 B2 JP5753344 B2 JP 5753344B2 JP 2009224001 A JP2009224001 A JP 2009224001A JP 2009224001 A JP2009224001 A JP 2009224001A JP 5753344 B2 JP5753344 B2 JP 5753344B2
- Authority
- JP
- Japan
- Prior art keywords
- liquid
- oral composition
- menthol
- composition
- polyoxyethylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 50
- 239000007788 liquid Substances 0.000 claims description 52
- -1 polyoxyethylene Polymers 0.000 claims description 35
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims description 21
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 20
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000004359 castor oil Substances 0.000 claims description 13
- 235000019438 castor oil Nutrition 0.000 claims description 13
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 13
- 239000003205 fragrance Substances 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 description 25
- 235000019634 flavors Nutrition 0.000 description 20
- 238000011156 evaluation Methods 0.000 description 18
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 239000002736 nonionic surfactant Substances 0.000 description 13
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 12
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 229940085605 saccharin sodium Drugs 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000000551 dentifrice Substances 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 5
- 229940038773 trisodium citrate Drugs 0.000 description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 239000002324 mouth wash Substances 0.000 description 4
- 229940051866 mouthwash Drugs 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 235000010447 xylitol Nutrition 0.000 description 4
- 239000000811 xylitol Substances 0.000 description 4
- 229960002675 xylitol Drugs 0.000 description 4
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000000417 fungicide Substances 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- SVIJYLPSHPPVQF-UHFFFAOYSA-N 2-[2,2-diaminoethyl(dodecyl)amino]acetic acid Chemical compound CCCCCCCCCCCCN(CC(N)N)CC(O)=O SVIJYLPSHPPVQF-UHFFFAOYSA-N 0.000 description 2
- YOBWBLFILQYRFY-UHFFFAOYSA-N 2-hexadecylpyridine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCC1=CC=CC=[NH+]1 YOBWBLFILQYRFY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- HKKXJKUATKEWDT-UHFFFAOYSA-N 2-ethyl-2-(tetradecylamino)butanoic acid Chemical compound C(CCCCCCCCCCCCC)NC(C(=O)O)(CC)CC HKKXJKUATKEWDT-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 238000005311 autocorrelation function Methods 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 150000002307 glutamic acids Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229940070802 palmitoyl glutamate Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、透明で香味に優れた液体若しくは液状口腔用組成物に関する。さらに詳しくは、l−メントールとノニオン性界面活性剤を含有する口腔用組成物において、1,3−プロパンジオールを配合した香味の良い液体若しくは液状の口腔用組成物に関する。 The present invention relates to a liquid or liquid oral composition that is transparent and excellent in flavor. More specifically, the present invention relates to an oral composition containing l-menthol and a nonionic surfactant, and a liquid or liquid oral composition containing 1,3-propanediol and having a good flavor.
液体若しくは液状の口腔用組成物は、組成物を希釈せずそのままの濃度で、一定時間口腔内に滞留させることで使用するため、組成物自体が有する味や匂いを強く感じ易い特徴がある。したがって、液体若しくは液状の口腔用組成物を開発する際には、嗜好性の高い香味を実現させるために、他の口腔用組成物に比べて高い技術が必要である。一般的に、液体若しくは液状の口腔用組成物には、スッキリ感や香味立ちを良くして嗜好性を高める目的でl−メントールを配合されている。l−メントールは水に溶解しないため、通常界面活性剤や多価アルコールが併せて配合されている。しかし、これらの界面活性剤や多価アルコールを配合すると組成物の味が悪くなったり、原料臭が強く香味立ちを妨げたり、スッキリした香味を損なったりするため、課題となっている。 Since the liquid or liquid oral composition is used by retaining the composition in the oral cavity for a certain period of time without diluting the composition, there is a feature that the taste and smell of the composition itself can be felt strongly. Therefore, when developing a liquid or liquid oral composition, a technique higher than that of other oral compositions is required in order to achieve a highly palatable flavor. Generally, l-menthol is blended in a liquid or liquid oral composition for the purpose of improving a refreshing feeling and flavor and improving palatability. Since l-menthol does not dissolve in water, a surfactant and a polyhydric alcohol are usually blended together. However, when these surfactants and polyhydric alcohols are blended, the composition becomes unsatisfactory, the raw material odor is strong and the flavor is prevented, and the refreshing flavor is impaired.
この課題に対して、特定のメントール誘導体を配合することで、ノニオン界面活性剤由来の異味、べたつき、刺激が無く、良好な爽快感を与える液体口腔用組成物を提供する技術(特許文献1)、特定量のノニオン界面活性剤に加えて、少量のアニオン界面活性剤と多量の糖アルコールを配合することで、香料成分を安定に溶解し、かつ界面活性剤等の刺激及び異味が抑制された液体口腔用組成物を提供する技術(特許文献2)、糖脂肪酸エステル、炭素数12〜18のカルボン酸エステル化合物及び特定のテルペン化合物を配合することでメントールを安定に可溶化すると共に風味が良く刺激性の少ない液体口腔用組成物を提供する技術(特許文献3)、エリスリトール、特定のHLBを有する非イオン性界面活性剤及びエタノールを配合することで、メントールを安定に溶解すると共に苦味や刺激が少ない液体若しくは液状の口腔用組成物を提供する技術(特許文献4)などが提案されている。しかしながら、未だ十分な効果が得られておらず、より効果の高い技術の開発が望まれていた。 In order to solve this problem, a technology for providing a liquid oral composition that does not have a taste, stickiness, or irritation derived from a nonionic surfactant and gives a good refreshing feeling by blending a specific menthol derivative (Patent Document 1) In addition to a specific amount of nonionic surfactant, by adding a small amount of anionic surfactant and a large amount of sugar alcohol, the fragrance component was stably dissolved, and the irritation and taste of the surfactant were suppressed. A technique for providing a liquid oral composition (Patent Document 2), a sugar fatty acid ester, a carboxylic acid ester compound having 12 to 18 carbon atoms and a specific terpene compound, solubilizing menthol stably and having a good flavor A technology that provides a composition for liquid oral cavity with less irritation (Patent Document 3), erythritol, nonionic surfactant having specific HLB and ethanol In Rukoto, such techniques to provide oral compositions of bitter or impoverished liquid or liquid (Patent Document 4) have been proposed as to dissolve the menthol stable. However, a sufficient effect has not yet been obtained, and development of a more effective technique has been desired.
本発明は、ノニオン界面活性剤由来の異味や刺激感を低減するとともに香味立ちが良くスッキリとした使用感を得られることを特徴とする透明かつ液体若しくは液状の口腔用組成物を提供することを目的とする。 The present invention provides a transparent, liquid or liquid oral composition characterized by reducing the off-flavor and irritation derived from nonionic surfactants and obtaining a refreshing feeling with a good flavor. Objective.
本発明者らは、上記問題を解決すべく鋭意検討を重ねた結果、驚くべきことに、l−メントールと1,3−プロパンジオールを配合することにより、ノニオン界面活性剤由来の異味や刺激感を低減するとともに香味立ちが良くスッキリとした使用感を得られることを見出し、本発明を完成するに至った。 As a result of intensive investigations to solve the above problems, the present inventors have surprisingly found that by adding l-menthol and 1,3-propanediol, the taste and irritation caused by the nonionic surfactant As a result, the present inventors have found that it is possible to obtain a refreshing feeling with a good flavor and a good flavor.
すなわち、本発明は、下記の態様を含むものである。
項1. l−メントール及びノニオン界面活性剤を配合した組成物において、1,3−プロパンジオールを配合したことを特徴とする液体若しくは液状の口腔用組成物。
項2.ノニオン界面活性剤が、ポリオキシエチレン硬化ヒマシ油であることを特徴とする項1に記載の液体若しくは液状の口腔用組成物。
項3.l−メント−ルの配合量が0.001〜0.5質量%であることを特徴とする項1または2の何れかに記載の液体若しくは液状の口腔用組成物。
項4.1,3−プロパンジオールの配合量が、1〜10質量%であることを特徴とする項1〜3の何れかに記載の液体若しくは液状の口腔用組成物。
That is, the present invention includes the following aspects.
Item 1. A liquid or liquid oral composition characterized in that 1,3-propanediol is blended in a composition blended with l-menthol and a nonionic surfactant.
Item 2. Item 2. The liquid or liquid oral composition according to Item 1, wherein the nonionic surfactant is polyoxyethylene hydrogenated castor oil.
Item 3. Item 3. The liquid or liquid oral composition according to Item 1 or 2, wherein the amount of l-menthol is 0.001 to 0.5% by mass.
Item 4. The liquid or liquid oral composition according to any one of Items 1 to 3, wherein the amount of 1,3-propanediol is 1 to 10% by mass.
本発明の液状若しくは液状の口腔用組成物は、透明でかつノニオン界面活性剤由来の異味や刺激感を低減するとともに香味立ちが良くスッキリとした使用感を与えることが可能となる。 The liquid or liquid oral composition of the present invention is transparent and can reduce the off-flavor and irritation derived from the nonionic surfactant, and can give a refreshing feeling with a good flavor.
以下、本発明について、さらに詳細に説明する。 Hereinafter, the present invention will be described in more detail.
本発明に用いる1,3−プロパンジオールは、無色油状の液体であり、トリメチレングリコール、1,3−ジヒドロキシプロパンとも言われ、ポリエステルの製造などに広く使用されている。配合量は特に限定するものではないが、一般に0.1〜40質量%配合することができ、1〜20質量%が好ましく、1〜10質量%がより好ましい。また、キシリトールやグリセリンと併用する場合は、1〜3質量%が最も好ましい。 1,3-propanediol used in the present invention is a colorless oily liquid, is also called trimethylene glycol and 1,3-dihydroxypropane, and is widely used in the production of polyesters. Although a compounding quantity is not specifically limited, Generally 0.1-40 mass% can be mix | blended, 1-20 mass% is preferable and 1-10 mass% is more preferable. Moreover, when using together with a xylitol or glycerol, 1-3 mass% is the most preferable.
本発明に用いるl−メントールは、l−メントールが含有していれば特に限定されず、たとえば化学合成で得られたl−メントール、植物から製造された天然由来のl−メントール、さらにはdl体や精油成分などが混合しているものも使用することができる。これらのl−メントールを含有する原料は単独で又は2種以上を適宜組み合わせて配合でき、その配合量は特に限定するものではないが、0.001〜0.5質量%であり、その中でも香味の点から、0.005〜0.3質量%が好ましく、0.01〜0.2質量%が最も好ましい。 The l-menthol used in the present invention is not particularly limited as long as l-menthol contains, for example, l-menthol obtained by chemical synthesis, naturally-derived l-menthol produced from a plant, and dl form Or a mixture of essential oil components can also be used. The raw materials containing these l-menthols can be blended alone or in appropriate combination of two or more, and the blending amount is not particularly limited, but is 0.001 to 0.5% by mass, and among them the flavor From this point, 0.005 to 0.3 mass% is preferable, and 0.01 to 0.2 mass% is most preferable.
本発明に用いるノニオン界面活性剤は、通常化粧品や医薬品で使用することのできるものであれば限定されず、たとえば、ポリオキシエチレン硬化ヒマシ油、ショ糖脂肪酸エステル、多価アルコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、脂肪酸アルカノールアミド、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレングリコール脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテルなどが挙げられる。この中でもポリオキシエチレン硬化ヒマシ油が好ましい。ポリオキシエチレン硬化ヒマシ油としては、エチレンオキシドの平均重合度が、5、10、20、30、40、50、60、80、100モルの化合物が市販されており、この中でも、ポリオキシエチレン(40)硬化ヒマシ油、ポリオキシエチレン(60)硬化ヒマシ油が好ましい。これらノニオン界面活性剤は単独で又は2種以上を適宜組み合わせて配合でき、それらの配合量は特に限定するものではないが、0.01〜5質量%であり、0.05〜2質量%が好ましい。 The nonionic surfactant used in the present invention is not limited as long as it can be usually used in cosmetics and pharmaceuticals. For example, polyoxyethylene hydrogenated castor oil, sucrose fatty acid ester, polyhydric alcohol fatty acid ester, glycerin fatty acid Ester, polyoxyethylene glycerin fatty acid ester, polyglycerin fatty acid ester, fatty acid alkanolamide, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, poly Examples thereof include oxyethylene polyoxypropylene alkyl ether. Among these, polyoxyethylene hydrogenated castor oil is preferable. As polyoxyethylene hydrogenated castor oil, compounds having an average degree of polymerization of ethylene oxide of 5, 10, 20, 30, 40, 50, 60, 80, 100 mol are commercially available. Among these, polyoxyethylene (40 ) Hydrogenated castor oil, polyoxyethylene (60) hydrogenated castor oil is preferred. These nonionic surfactants can be blended alone or in appropriate combination of two or more, and the blending amount thereof is not particularly limited, but is 0.01 to 5% by mass, and 0.05 to 2% by mass. preferable.
本発明の液体若しくは液状の口腔用組成物には、上記の成分以外にも他の成分を配合することができる。例えば、ノニオン界面活性剤以外の界面活性剤、湿潤剤、甘味剤、香味剤、薬効剤、増粘剤、pH調整剤、着色剤、防腐剤等を、本発明の効果を損なわない範囲で適宜配合することができる。 In addition to the above components, other components can be blended in the liquid or liquid oral composition of the present invention. For example, surfactants other than nonionic surfactants, wetting agents, sweeteners, flavoring agents, medicinal agents, thickeners, pH adjusters, coloring agents, preservatives, etc. are appropriately selected within a range that does not impair the effects of the present invention. Can be blended.
ノニオン性界面活性剤以外の界面活性剤としては、ラウリル硫酸ナトリウム、ポリオキシエチレンラウリル硫酸ナトリウム、ミリスチル硫酸ナトリウム、N−パルミトイルグルタミン酸ナトリウム、サルコシンナトリウム、ポリオキシエチレンアルキル(12〜16)エーテルリン酸などに代表されるアニオン性界面活性剤、N−ラウリルジアミノエチルグリシン、N−ミリスチルジエチルグリシン等のN−アルキルジアミノエチルグリシン、N−アルキル−N−カルボキシメチルアンモニウムベタイン、ラウリルジメチルアミノ酢酸ベタインに代表される両性界面活性剤などが挙げられる。これらの界面活性剤は、単独で又は2種以上を適宜組み合わせて配合できる。 Examples of surfactants other than nonionic surfactants include sodium lauryl sulfate, polyoxyethylene sodium lauryl sulfate, sodium myristyl sulfate, sodium N-palmitoyl glutamate, sodium sarcosine, polyoxyethylene alkyl (12-16) ether phosphate, and the like. Anionic surfactants such as N-lauryldiaminoethylglycine, N-myristyldiethylglycine, and other N-alkyldiaminoethylglycines, N-alkyl-N-carboxymethylammonium betaines, and lauryldimethylaminoacetic acid betaines Amphoteric surfactants. These surfactants can be blended alone or in appropriate combination of two or more.
湿潤剤としては、エタノール、グリセリン、ソルビット、エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、イソプレングリコール、ポリエチレングリコール、ポリプロピレングリコール、キシリトール、マルチトール、ラクチトール、パラチニットなどが挙げられる。これらの湿潤剤は、単独で又は2種以上を適宜組み合わせて配合することができる。 Examples of the wetting agent include ethanol, glycerin, sorbit, ethylene glycol, propylene glycol, 1,3-butylene glycol, isoprene glycol, polyethylene glycol, polypropylene glycol, xylitol, maltitol, lactitol, and palatinit. These wetting agents can be blended alone or in appropriate combination of two or more.
甘味剤としては、サッカリンナトリウム、ステビオサイド、グリチルリチン、キシリット、スクラロース、キシリトール、パラチノース、パラチニット、エリスリトール、マルチトールなどが挙げられる。これらの甘味剤は、単独で又は2種以上を適宜組み合わせて配合することができる。 Examples of the sweetener include saccharin sodium, stevioside, glycyrrhizin, xylit, sucralose, xylitol, palatinose, palatinit, erythritol, maltitol and the like. These sweeteners can be blended alone or in appropriate combination of two or more.
香味剤としては、カルボン酸、アネトール、オイゲノール、サリチル酸メチル、リモネン、オシメン、n−デシルアルコール、シトロネール、α−テルピネオール、メチルアセタート、シトロネニルアセタート、メチルオイゲノール、シネオール、リナロール、エチルリナロール、チモールなどの香料が挙げられる。これらの香味剤は、単独または2種以上を組み合わせて組成物全量に対して0.001〜1質量%、好ましくは0.01〜0.5質量%の割合で配合することができる。 As a flavoring agent, carboxylic acid, anethole, eugenol, methyl salicylate, limonene, ocimene, n-decyl alcohol, citronell, α-terpineol, methyl acetate, citronenyl acetate, methyl eugenol, cineol, linalool, ethyl linalool, Examples include fragrances such as thymol. These flavoring agents can be blended in a proportion of 0.001 to 1% by mass, preferably 0.01 to 0.5% by mass, alone or in combination of two or more.
薬効剤としては、たとえば、塩化セチルピリジニウム、塩酸クロルヘキシジン、塩化ベンゼトニウムなどのカチオン性殺菌剤、ドデシルジアミノエチルグリシンなどの両性殺菌剤、トリクロサン、イソプロピルメチルフェノールなどの非イオン性殺菌剤、デキストラナーゼ、アミラーゼ、プロテアーゼ、ムタナーゼ、リゾチーム、溶菌酵素(リテックエンザイム)などの酵素、トラネキサム酸、イプシロンアミノカプロン酸、アルミニウムクロルヒドロキシルアラントイン、ジヒドロコレステロール、グリチルリチン酸類、グリチルレチン酸などの坑炎症剤、チアミン類、リボフラビン類、ピリドキシン類、ビタミンB12類、葉酸、ナイアシン、ビオチン、パントテン酸、ビタミンC、ビタミンA、ビタミンD類、ビタミンE類、ビタミンKなどのビタミン類、その他、グリセロフォスフェート、クロロフィル、塩化ナトリウムなどが挙げられ、これらを単独または2種以上を組み合わせて配合することができる。 Medicinal agents include, for example, cationic fungicides such as cetylpyridinium chloride, chlorhexidine hydrochloride, benzethonium chloride, amphoteric fungicides such as dodecyldiaminoethylglycine, nonionic fungicides such as triclosan and isopropylmethylphenol, dextranase, Anti-inflammatory agents such as amylase, protease, mutanase, lysozyme, lytic enzyme (lytechenzyme), tranexamic acid, epsilon aminocaproic acid, aluminum chlorohydroxyl allantoin, dihydrocholesterol, glycyrrhizic acid, glycyrrhetinic acid, thiamines, riboflavins, Pyridoxine, vitamin B12, folic acid, niacin, biotin, pantothenic acid, vitamin C, vitamin A, vitamin D, vitamin E, vitamin K, etc. Glutamic acids, other, glycerophosphate, chlorophyll, sodium chloride and the like, can be blended in combination alone or in combination.
増粘剤としては、ヒドロキシエチルセルロース、カルボキシメチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カチオン変性ヒドロキシエチルセルロースなどのセルロース系化合物、グルコマンナン、タラガム、グアーガム、ローカストビーンガム、タマリンドシードガムなどの天然ガム類、その他、キサンタンガム、プルラン、ジェランガムなどが挙げられ、これらを単独または2種以上を組み合わせて配合することができる。 As thickeners, cellulose compounds such as hydroxyethylcellulose, carboxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, cation-modified hydroxyethylcellulose, natural gums such as glucomannan, tara gum, guar gum, locust bean gum, tamarind seed gum, In addition, xanthan gum, pullulan, gellan gum and the like can be mentioned, and these can be blended alone or in combination of two or more.
本発明の液体若しくは液状の口腔用組成物は、組成物の粘度が150mPa・s以下であることが好ましい。より好ましくは100mPa・s以下であり、もっとも好ましくは35mPa・s以下である。150mPa・sを越えると使用感が悪くなる可能性があるため好ましくない。組成物の粘度測定は、円錐平板型回転粘度計(E型粘度計)を用いて、25℃、20r.p.m.、60秒の条件で行う。 The liquid or liquid oral composition of the present invention preferably has a viscosity of 150 mPa · s or less. More preferably, it is 100 mPa * s or less, Most preferably, it is 35 mPa * s or less. If it exceeds 150 mPa · s, the usability may be deteriorated, which is not preferable. The viscosity of the composition is measured using a conical plate type rotational viscometer (E type viscometer) under the conditions of 25 ° C., 20 rpm and 60 seconds.
本発明の液体若しくは液状の口腔用組成物は、組成物の透明であることが好ましい。組成物の透明度合いは、目視または色差計での測定を行なった。使用する色差計としては、特に制限はなく、市販の色差計或いは分光光度計を用いることができる。例えば、島津製作所製の分光光度計(UV-2450)を用いて測定し、測定値の解析はUVPC OPTIONAL COLOR ANALYSIS SOFTWARE等を用いることにより、白色度(WB値、JIS基準)、黄色度(YI値)により評価できる。白色度は90以上であることが好ましくより好ましくは95以上である。黄色度は6以下であることが好ましくより好ましくは3以下である。また、経時での透明安定性は組成物の平均粒子径(流体力学的径)を測定することで行った。平均粒子径の測定は、光子相関法で求めた自己相関関数よりキュムラント法で解析することにより求めることができる。例えばマルバーン社(Malvern Instruments Ltd)製、ゼータサイザーナノZS(Zetasizer NanoZS)を用い、Z−averag size値として測定できる。平均粒子径は50nm以下であることが好ましくより好ましくは40nm以下である。 The liquid or liquid oral composition of the present invention is preferably transparent in the composition. The transparency of the composition was measured visually or with a color difference meter. There is no restriction | limiting in particular as a color difference meter to be used, A commercially available color difference meter or a spectrophotometer can be used. For example, measurement is performed using a spectrophotometer (UV-2450) manufactured by Shimadzu Corporation, and analysis of the measured value is performed using UVPC OPTIONAL COLOR ANALYSIS SOFTWARE, etc., so that whiteness (WB value, JIS standard), yellowness (YI) Value). The whiteness is preferably 90 or more, more preferably 95 or more. The yellowness is preferably 6 or less, more preferably 3 or less. In addition, the transparent stability over time was measured by measuring the average particle size (hydrodynamic diameter) of the composition. The measurement of the average particle diameter can be obtained by analyzing by the cumulant method from the autocorrelation function obtained by the photon correlation method. For example, it can be measured as a Z-averag size value using a Zetasizer Nano ZS (Malvern Instruments Ltd.). The average particle size is preferably 50 nm or less, more preferably 40 nm or less.
本発明の液体若しくは液状の口腔用組成物は、液体歯磨、水歯磨、洗口剤、マウススプレー、うがい薬等として適用できる。 The liquid or liquid oral composition of the present invention can be applied as liquid dentifrice, water dentifrice, mouthwash, mouth spray, mouthwash and the like.
以下、本発明を具体的に説明するが、本発明は下記の例に限定されるものではない。なお、文中の配合量は、特に規定がない限り質量%を示す。 Hereinafter, the present invention will be specifically described, but the present invention is not limited to the following examples. In addition, the compounding quantity in a sentence shows the mass% as long as there is no special regulation.
香味の評価
香味の評価は、以下の手順に従って実施した。専門パネル3名に対して、4段階の評点による絶対評価を、常法により製造した実施例1〜7及び比較例1〜6に対して実施した。試験は、各組成物を10ml取り、口中に約20秒間含んだ後に吐き出し、その直後に評価した。得られた結果は集計し、個々の評価項目毎に評点の平均値を算出した。評価結果は、下記の基準に従って行なった。
評点 4 : 非常に良い/全く感じない
3 : 良い/感じない
2 : 悪い/感じる
1 : 非常に悪い/かなり感じる
評価基準 ◎ : 3以上
○ : 3〜2
× : 2未満
総合評価 ◎ : 全ての香味の評価が◎
○ : 香味の評価が◎か○
× : 上記以外
Evaluation of flavor The evaluation of flavor was performed according to the following procedure. Absolute evaluations based on four grades were carried out on three specialized panels for Examples 1 to 7 and Comparative Examples 1 to 6 produced by a conventional method. In the test, 10 ml of each composition was taken and contained in the mouth for about 20 seconds. The obtained results were tabulated and the average score was calculated for each evaluation item. The evaluation results were performed according to the following criteria.
Score 4: Very good / not at all
3: Good / Don't feel
2: Bad / feel
1: Very bad / feels pretty
Evaluation criteria ◎: 3 or more
○: 3 to 2
×: Less than 2
Overall evaluation ◎: Evaluation of all flavors is ◎
○: Is the flavor evaluation ◎?
×: Other than above
透明性の評価(目視判定)
透明性の評価は目視で行なった。香味の評価に供した各サンプルを、直径約5cmの円筒形のサンプル瓶に充填し、瓶横から内容物を観察した場合の透明度を評価した。透明であると認めた場合を○、それ以外を×とした。
Transparency evaluation (visual judgment)
The transparency was evaluated visually. Each sample subjected to flavor evaluation was filled into a cylindrical sample bottle having a diameter of about 5 cm, and the transparency when the contents were observed from the side of the bottle was evaluated. The case where it was recognized as transparent was marked with ◯, and the others were marked with ×.
透明性の評価(色差計測定)
色差計測定による透明性の評価は、下記の手順に従って実施した。香味の評価に供した各サンプルを、島津製作所製の分光光度計(UV-2450)を用い、10度視野に基づくX10Y10Z10表色系によって測定し、白色度(WB値、JIS基準)、黄色度(YI値)を評価した。測定条件は、ガラスセルを使用し、測定モードは透過率、視野角は10℃とし、解析はUVPC OPTIONAL COLOR ANALYSIS SOFTWAREで行った。
評価基準 ○ : WB 90以上、YI 6未満
× : WB 90未満、YI 6以上
Transparency evaluation (color difference meter measurement)
Transparency evaluation by color difference measurement was performed according to the following procedure. Each sample subjected to flavor evaluation was measured with a spectrophotometer (UV-2450) manufactured by Shimadzu Corporation using an X 10 Y 10 Z 10 color system based on a 10 ° field of view, and the whiteness (WB value, JIS). Standard) and yellowness (YI value) were evaluated. The measurement conditions were a glass cell, the measurement mode was transmittance, the viewing angle was 10 ° C., and the analysis was performed with UVPC OPTIONAL COLOR ANALYSIS SOFTWARE.
Evaluation criteria ○: WB 90 or more, less than YI 6
X: Less than WB 90, YI 6 or more
透明安定性の評価
透明安定性の評価は、下記の手順に従って実施した。香味の評価に供した各サンプルを、マルバーン社(Malvern Instruments Ltd)製、セータサイザーナノZS(Zetasizer NanoZS)を用いてZ−average size値を測定し、その値を以って評価した。測定には、ディスポザブルキュベットセルを使用し、測定温度25℃とした。透明安定性の評価は下記の基準に従って行なった。
評価基準 ○ : 50未満
× : 50以上
Evaluation of transparency stability The transparency stability was evaluated according to the following procedure. Each sample subjected to flavor evaluation was measured using a Z-average size value measured by a Zetasizer Nano ZS (Malvern Instruments Ltd.) and a Zetasizer NanoZS. For the measurement, a disposable cuvette cell was used, and the measurement temperature was 25 ° C. The transparent stability was evaluated according to the following criteria.
Evaluation criteria ○: Less than 50
×: 50 or more
得られた結果を表1および表2に示す。 The obtained results are shown in Tables 1 and 2.
表1、表2に示した通り、1,3−プロパンジオールを配合した液体若しくは液状の口腔用組成物は、優れた香味を示し、高い透明性を維持できることが判った。一方、類似化合物である1,2−プロパンジオールや1,3―ブタンジオールなどでは同様の効果を得ることができなかった。 As shown in Table 1 and Table 2, it was found that the liquid or liquid oral composition containing 1,3-propanediol showed an excellent flavor and maintained high transparency. On the other hand, 1,2-propanediol, 1,3-butanediol and the like, which are similar compounds, could not obtain the same effect.
以下に、本発明に係る液体若しくは液状の口腔用組成物の処方例を示す。特に規定しない限り配合量は質量%を示す。 Below, the formulation example of the liquid or liquid oral composition which concerns on this invention is shown. Unless otherwise specified, the blending amount represents mass%.
処方例1
常法に従って、液体歯磨剤を調製した。
成分 配合量
グリセリン 10.0
1,3−プロパンジオール 3.0
l−メントール 0.05
ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.2
塩化セチルピリジニウム 0.05
トラネキサム酸 0.05
クエン酸 0.01
クエン酸3ナトリウム 0.1
パラオキシ安息香酸メチル 0.1
香料 0.05
サッカリンナトリウム 0.02
精製水 残部
合計 100.0
Formulation Example 1
A liquid dentifrice was prepared according to a conventional method.
Ingredients Amount
Glycerin 10.0
1,3-propanediol 3.0
l-Menthol 0.05
Polyoxyethylene (60E.O.) hydrogenated castor oil 0.2
Cetylpyridinium chloride 0.05
Tranexamic acid 0.05
Citric acid 0.01
Trisodium citrate 0.1
Methyl paraoxybenzoate 0.1
Fragrance 0.05
Saccharin sodium 0.02
Purified water balance
Total 100.0
処方例2
常法に従って、液体歯磨を調製した。
成分 配合量
グリセリン 7.0
1,3−プロパンジオール 5.0
l−メントール 0.1
ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.4
酢酸トコフェロール 0.02
クエン酸 0.01
クエン酸3ナトリウム 0.1
安息香酸ナトリウム 0.2
香料 0.1
サッカリンナトリウム 0.02
精製水 残部
合計 100.0
Formulation Example 2
A liquid dentifrice was prepared according to a conventional method.
Ingredients Amount
Glycerin 7.0
1,3-propanediol 5.0
l-Menthol 0.1
Polyoxyethylene (40E.O.) hydrogenated castor oil 0.4
Tocopherol acetate 0.02
Citric acid 0.01
Trisodium citrate 0.1
Sodium benzoate 0.2
Fragrance 0.1
Saccharin sodium 0.02
Purified water balance
Total 100.0
処方例3
常法に従って、洗口剤を調製した。
成分 配合量
キシリトール 3.0
1,3−プロパンジオール 7.0
l−メントール 0.05
ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.4
イソプロピルメチルフェノール 0.05
クエン酸 0.01
クエン酸3ナトリウム 0.1
香料 0.05
サッカリンナトリウム 0.02
精製水 残部
合計 100.0
Formulation Example 3
A mouthwash was prepared according to a conventional method.
Ingredients Amount
Xylitol 3.0
1,3-propanediol 7.0
l-Menthol 0.05
Polyoxyethylene (60E.O.) hydrogenated castor oil 0.4
Isopropyl methylphenol 0.05
Citric acid 0.01
Trisodium citrate 0.1
Fragrance 0.05
Saccharin sodium 0.02
Purified water balance
Total 100.0
処方例4
常法に従って、洗口剤を調製した。
成分 配合量
グリセリン 15.0
1,3−プロパンジオール 1.0
l−メントール 0.1
ショ糖ラウリン酸エステル 0.3
イソプロピルメチルフェノール 0.05
クエン酸 0.01
クエン酸3ナトリウム 0.1
安息香酸ナトリウム 0.2
香料 0.1
サッカリンナトリウム 0.02
精製水 残部
合計 100.0
Formulation Example 4
A mouthwash was prepared according to a conventional method.
Ingredients Amount
Glycerin 15.0
1,3-propanediol 1.0
l-Menthol 0.1
Sucrose laurate 0.3
Isopropyl methylphenol 0.05
Citric acid 0.01
Trisodium citrate 0.1
Sodium benzoate 0.2
Fragrance 0.1
Saccharin sodium 0.02
Purified water balance
Total 100.0
処方例5
常法に従って、マウススプレーを調製した。
成分 配合量
エタノール 35.0
グリセリン 10.0
1,3−プロパンジオール 3.0
l−メントール 0.5
ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0
塩化セチルピリジニウム 0.05
クエン酸 0.1
クエン酸3ナトリウム 0.1
香料 0.9
サッカリンナトリウム 0.1
精製水 残部
合計 100.0
Formulation Example 5
A mouse spray was prepared according to a conventional method.
Ingredients Amount
Ethanol 35.0
Glycerin 10.0
1,3-propanediol 3.0
l-Menthol 0.5
Polyoxyethylene (60E.O.) hydrogenated castor oil 1.0
Cetylpyridinium chloride 0.05
Citric acid 0.1
Trisodium citrate 0.1
Fragrance 0.9
Saccharin sodium 0.1
Purified water balance
Total 100.0
処方例6
常法に従って、液状歯磨を調製した。
成分 配合量
ヒドロキシエチルセルロース 1.0
濃グリセリン 20.0
エタノール 10.0
1,3−プロパンジオール 3.0
l−メントール 0.3
ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0
フッ化ナトリウム 0.2
塩化セチルピリジニウム 0.05
パラオキシ安息香酸メチル 0.1
香料 0.3
サッカリンナトリウム 0.2
精製水 残部
合計 100.0
Formulation Example 6
A liquid dentifrice was prepared according to a conventional method.
Ingredients Amount
Hydroxyethyl cellulose 1.0
Concentrated glycerin 20.0
Ethanol 10.0
1,3-propanediol 3.0
l-Menthol 0.3
Polyoxyethylene (60E.O.) hydrogenated castor oil 1.0
Sodium fluoride 0.2
Cetylpyridinium chloride 0.05
Methyl paraoxybenzoate 0.1
Fragrance 0.3
Saccharin sodium 0.2
Purified water balance
Total 100.0
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009224001A JP5753344B2 (en) | 2009-09-29 | 2009-09-29 | Oral composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009224001A JP5753344B2 (en) | 2009-09-29 | 2009-09-29 | Oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011073979A JP2011073979A (en) | 2011-04-14 |
JP5753344B2 true JP5753344B2 (en) | 2015-07-22 |
Family
ID=44018344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009224001A Expired - Fee Related JP5753344B2 (en) | 2009-09-29 | 2009-09-29 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5753344B2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5620119B2 (en) * | 2010-02-15 | 2014-11-05 | ライオン株式会社 | Non-diluted liquid oral composition and method of use |
CA2866243C (en) * | 2012-03-09 | 2019-08-06 | Kraft Foods Group Brands Llc | Food and beverage products containing 1,3-propanediol and methods of modifying flavor release using 1,3-propanediol |
CN104203004B (en) | 2012-03-09 | 2017-07-07 | 卡夫食品集团品牌有限责任公司 | Flavour characteristic suppression is aoxidized in edible composition |
JP6614071B2 (en) * | 2016-09-05 | 2019-12-04 | ライオン株式会社 | Liquid oral composition |
JP7153007B2 (en) * | 2019-12-18 | 2022-10-13 | 花王株式会社 | Liquid oral composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007095255A2 (en) * | 2006-02-10 | 2007-08-23 | Dupont Tate & Lyle Bio Products Company, Llc | Biodegradable compositions comprising renewably-based, biodegradable 1.3-propanediol |
-
2009
- 2009-09-29 JP JP2009224001A patent/JP5753344B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2011073979A (en) | 2011-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5690811B2 (en) | Liquid oral composition and method for producing the same | |
EP3238703B1 (en) | Method for producing liquid composition for oral cavity and liquid composition for oral cavity | |
JP2019052110A (en) | Oral composition | |
JP5658888B2 (en) | Liquid oral composition | |
WO2018194111A1 (en) | Oral biofilm removing agent and oral composition | |
JP5753344B2 (en) | Oral composition | |
WO2013094504A1 (en) | Oral composition | |
JP6125859B2 (en) | Composition for external use | |
JP5842565B2 (en) | Mouthwash composition and method for inhibiting discoloration in mouthwash composition | |
JP3613631B2 (en) | Oral liquid composition | |
JP5690744B2 (en) | Emulsified liquid oral composition and method for producing the same | |
JP2016222582A (en) | Oral cavity composition | |
JP5570777B2 (en) | Oral composition | |
WO2017110582A1 (en) | Composition for oral cavity | |
WO2016133063A1 (en) | Oral liquid composition | |
JP5825088B2 (en) | Liquid oral composition | |
JP2015089870A (en) | Liquid oral composition | |
JP6939096B2 (en) | Liquid oral composition | |
JP2008031070A (en) | Liquid composition for oral cavity | |
JP2016222556A (en) | Liquid oral composition | |
JP6173735B2 (en) | Dentifrice composition | |
JP5720352B2 (en) | Liquid oral composition | |
CN111031999B (en) | Toothpaste composition | |
JPWO2016136719A1 (en) | Dentifrice composition | |
JP5739608B2 (en) | Liquid oral composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120911 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130806 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140204 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140404 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20141111 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150202 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20150304 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150519 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150522 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5753344 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |